Company intelligence / Profile preview

CCRM Enterprises

Toronto, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

CCRM Enterprises is the for-profit venture investment arm of CCRM, launched in late 2021. It focuses on early-stage regenerative medicine and cell & gene therapy ventures, addressing funding gaps in the Canadian ecosystem through pre-seed to later-stage investments. It leverages CCRM's manufacturing infrastructure and expertise to accelerate and de-risk high-potential companies.

Modalities: Cell therapyGene therapy
Industry: Investors

Partnerships

Notch TherapeuticsExacis Biotherapeutics

Beyond the preview

Go deeper on CCRM Enterprises.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CCRM Enterprises.

Explore the full profile